Platelet glycoprotein IIb/IIIa inhibitors - Basic and clinical aspects

被引：50

作者：

Nurden, AT ^{[1
]}

Poujol, C

Durrieu-Jais, C

Nurden, P

机构：

[1] Hop Cardiol, CNRS, UMR 5533, F-33604 Pessac, France

[2] Hop Cardiol, Inst Federatif Rech Coeur Vaisseaux Thrombose, Unite Soins Intensifs, F-33604 Pessac, France

来源：

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 1999年 / 19卷 / 12期

关键词：

glycoproteins; abciximab; platelet aggregation; antithrombotic drugs;

D O I：

10.1161/01.ATV.19.12.2835

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2835 / 2840

页数：6

共 41 条

[1]

Berkowitz SD, 1997, CIRCULATION, V95, P809

[2] Expression of markers of platelet activation and the interpatient variation in response to abciximab [J].

Bihour, C ;

Durrieu-Jaïs, C ;

Macchi, L ;

Poujol, C ;

Coste, P ;

Besse, P ;

Nurden, P ;

Nurden, AT .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (02) :212-219

[3] RGD peptides induce apoptosis by direct caspase-3 activation [J].

Buckley, CD ;

Pilling, D ;

Henriquez, NV ;

Parsonage, G ;

Threlfall, K ;

Scheel-Toellner, D ;

Simmons, DL ;

Albar, AN ;

Lord, JM ;

Salmon, M .

NATURE, 1999, 397 (6719) :534-539

[4]

BYZOVA TV, 1997, J BIOL CHEM, V272, P183

[5] USE OF A MONOCLONAL-ANTIBODY DIRECTED AGAINST THE PLATELET GLYCOPROTEIN IIB/IIIA RECEPTOR IN HIGH-RISK CORONARY ANGIOPLASTY [J].

CALIFF, RM ;

SHADOFF, N ;

VALETT, N ;

BATES, E ;

GALEANA, A ;

KNOPF, W ;

SHAFTEL, J ;

BENDER, MJ ;

AVERSANO, T ;

RAQUENO, J ;

GURBEL, P ;

COWFER, J ;

COHEN, M ;

CROSS, P ;

BITTL, J ;

EDDINGS, K ;

TAYLOR, M ;

DEROSA, K ;

HATTEL, L ;

COOPER, L ;

ESHELMAN, B ;

FINTEL, D ;

NIEMYSKI, P ;

KLEIN, L ;

KENNEDY, H ;

THORNTON, T ;

KEREIAKES, D ;

MARTIN, L ;

ANDERSON, L ;

HIGBY, N ;

ELLIS, S ;

BREZINA, K ;

GEORGE, B ;

CHAPEKIS, A ;

SMITH, D ;

ANWAR, A ;

GERBER, TL ;

PRITCHARD, GL ;

MYLER, R ;

SHAW, R ;

MURPHY, M ;

WARD, K ;

MADIGAN, NP ;

BLANKENSHIP, J ;

HALBERT, M ;

FLANAGAN, C ;

TANNENBAUM, M ;

POLICH, M ;

STEVENSON, C ;

TCHENG, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (14) :956-961

[6] Inhibition of platelet aggregation by abciximab but not by aspirin can be detected by a new point-of-care test, the hemostatus [J].

Coiffic, A ;

Cazes, E ;

Janvier, G ;

Forestier, F ;

Lanza, F ;

Nurden, A ;

Nurden, P .

THROMBOSIS RESEARCH, 1999, 95 (02) :83-91

[7]

Coller BS, 1997, J CLIN INVEST, V100, pS57

[8]

GEORGE JN, 1984, NEW ENGL J MED, V311, P1094

[9]

Gold HK, 1997, CIRCULATION, V95, P1755

[10] Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions [J].

Goto, S ;

Ikeda, Y ;

Saldívar, E ;

Ruggeri, ZM .

JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (02) :479-486

← 1 2 3 4 5 →